BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 964 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $209,000 | +1.5% | 2,437 | -4.2% | 0.09% | -18.4% |
| Q1 2020 | $206,000 | -4.6% | 2,545 | -1.6% | 0.11% | +11.8% |
| Q4 2019 | $216,000 | -4.4% | 2,586 | 0.0% | 0.10% | -13.6% |
| Q3 2019 | $226,000 | +1.8% | 2,586 | -4.8% | 0.12% | +3.5% |
| Q2 2019 | $222,000 | +0.9% | 2,716 | 0.0% | 0.11% | -1.7% |
| Q1 2019 | $220,000 | -46.3% | 2,716 | -56.4% | 0.12% | -4.9% |
| Q4 2018 | $410,000 | +70.8% | 6,232 | +100.0% | 0.12% | +2.5% |
| Q3 2018 | $240,000 | +4.3% | 3,116 | 0.0% | 0.12% | -3.3% |
| Q2 2018 | $230,000 | +10.0% | 3,116 | -3.1% | 0.12% | +4.2% |
| Q1 2018 | $209,000 | -0.9% | 3,216 | -1.5% | 0.12% | -4.1% |
| Q4 2017 | $211,000 | +3.4% | 3,266 | 0.0% | 0.12% | -1.6% |
| Q3 2017 | $204,000 | -0.5% | 3,266 | -3.8% | 0.12% | -5.3% |
| Q2 2017 | $205,000 | -21.2% | 3,396 | -8.8% | 0.13% | -29.4% |
| Q2 2015 | $260,000 | -3.3% | 3,724 | -5.2% | 0.19% | -3.6% |
| Q1 2015 | $269,000 | -9.1% | 3,929 | -2.8% | 0.19% | -13.0% |
| Q4 2014 | $296,000 | +15.6% | 4,044 | +13.3% | 0.22% | +9.9% |
| Q3 2014 | $256,000 | -0.8% | 3,569 | 0.0% | 0.20% | -1.9% |
| Q2 2014 | $258,000 | +4.5% | 3,569 | +6.3% | 0.21% | -5.0% |
| Q1 2014 | $247,000 | -15.1% | 3,359 | -19.6% | 0.22% | -15.8% |
| Q4 2013 | $291,000 | – | 4,179 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
| NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
| Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
| Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
| GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
| Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
| Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
| Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
| Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |